Monitoring as a Learning and Motivational Tool

Evidence-based Medical Monitoring: From Principles to Practice

Volumn , Issue , 2008, Pages 123-139

  Michie, Susan ^a   McCaffery, Kirsten ^b   Heneghan, Carl ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Hypothesis testing; Medical review; Motivational tool; Psychological factors; Self monitoring

Indexed keywords

EID: 84889323797     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470696323.ch10     Document Type: Chapter

References (82)

1. Lowy C. A memorable patient. Home glucose monitoring, who started it? BMJ 1998; 316: 1467.
2. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004; 329: 145-8.
3. Thoonen BP, Schermer TR, Van Den Boom G, et al. Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003; 58: 30-6.
4. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-11.
5. Coulter A. Patient information and shared decision-making in cancer care. Br J Cancer 2003; 89 (Suppl): S15-S16.
6. Davey HM, Barratt AL, Davey E, et al. Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expect 2002; 5: 330-40.
7. Feldman-Stewart D, Brundage MD, Hayter C, et al. What questions do patients with curable prostate cancer want answered? Med Decis Making 2000; 20: 7-19.
8. Krohne HW. The concept of coping modes: relating cognitive person variables to actual coping behaviour. Adv Behav Res Ther 1989; 11: 235-48.
9. Miller SM. To see or not to see. Cognitive informational styles in the coping process. In: Rosenbaum M (ed), Learned Resourcefulness. New York: Springer, 1991, pp. 95-126.
10. Lazarus RS, Folkman S. Stress, Appraisal and Coping. New York: Springer, 1984.
11. Shiloh S, Orgler-Shoob M. Monitoring: a dual process coping style. J Pers 2006; 74: 457-78.
12. Cioffi D. Asymmetry of doubt in medical self-diagnosis: the ambiguity of 'uncertain wellness'. J Pers Soc Psychol 1991; 61: 969-80.
13. World Health Organization. Adherence to long-term therapies. In: Evidence for Action. Geneva: World Health Organization, 2003.
14. Wilson W, Ary DV, Biglan A, Glasgow RE, Toobert DJ, Campbell DR. Psychosocial predictors of self-care behaviors (compliance) and glycemic control in non-insulin dependent diabetes mellitus. Diabetes Care 1986; 9: 614-22.
15. Wagner JA, Schnoll RA, Gipson MT. Development of a scale to measure adherence to self-monitoring of blood glucose with latent variable measurement. Diabetes Care 1998; 21: 1046-51.
16. Glasgow RE, Toobert DJ, Riddle M, Donnelly J, Mitchell DL, Calder D. Diabetesspecific social learning variables and self-care behaviors among persons with type II diabetes. Health Psychol 1989; 8: 285-303.
17. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; (1): CD001117.
18. Sawyer SM. Action plans, self-monitoring and adherence: changing behaviour to promote better self-management. Med J Aust 2002; 177:S72-S74.
19. Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care Med 2004; 170: 606-12.
20. Gigerenzer G. Reckoning with Risk. London: Penguin, 2002.
21. Wertz DC, Sorenson JC, Heeren TR. Clients' interpretations of risks provided in genetic counselling. Am J Hum Genet 1986; 39: 253-64.
22. Michie S, Lester K, Pinto J, Marteau TM. Communicating risk information in genetic counseling: an observational study. Health Educ Res 2005; 32: 589-98.
23. Channer KS, James MA, Papouchado M, Rees JR. Failure of a negative exercise test to reassure patients with chest pain. Q J Med 1987; 63: 315-22.
24. Lucock MP, White C, Peake MD, Morley S. Biased perception and recall of reassurance in medical patients. Br J Health Psychol 1998; 3: 237-43.
25. Fitzmaurice DA, Hobbs RD, Murray JA. Monitoring oral anticoagulation in primary care. BMJ 1996; 312: 1431-2.
26. Korotitsch WJ, Nelson-Gray RO. An overview of self-monitoring research in assessment and treatment. Psychol Assess 1999; 11: 415-25.
27. Hayes SC, Cavior N. Multiple tracking and the reactivity of self-monitoring: I. Negative behaviours. Behav Ther 1977; 8: 819-31.
28. Hayes SC, Cavior N. Multiple tracking and the reactivity of self-monitoring: II. Positive behaviours. Behav Assess 1980; 2: 283-96.
29. Lipinski DP, Black JL, Nelson RO, Ciminero AR. The influence of motivational variables on the reactivity and the reliability of self-recording. J Consult Clin Psychol 1975; 43: 637-46.
30. Mahoney MJ. Some applied issues in self-monitoring. In: Cone CD, Hawkins RP (eds), Behavioral Assessment: New Directions in Clinical Psychology. New York: Brunner/Mazel, 1977, pp. 241-54.
31. Waller J, McCaffery KJ, Kitchener H, Nazroo JN, Wardle J. Women's experiences of repeated HPV testing in the context of cervical screening: a qualitative study. Psychooncology 2007; 16: 196-204.
32. Jones MH, Singer A, Jenkins D. The mildly abnormal cervical smear: patient anxiety and choice of management. J R Soc Med 1996; 89: 257-60.
33. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango). Soc Sci Med 1997; 44: 681-92.
34. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54-9.
35. Michie S, Miles J, Weinman J. Patient-centredness in chronic illness: what is it and does it matter? Patient Educ Couns 2003; 51: 197-206.
36. Guerci B, Drouin P, Grange V, et al.; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-94.
37. Lavery LA, Higgins KR, Lanctôt DR, et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004; 27: 2642-7.
38. Craig KE. Self-observation in natural environments: reactive effects of behavior desirability and goal-setting. Cogn Ther Res 1978; 2: 39-56.
39. Kazdin AE. Reactive self-monitoring: the effects of response desirability, goal setting, and feedback. J Consult Clin Psychol 1974; 42: 704-16.
40. Fremouw WJ, Brown JP, Jr. The reactivity of addictive behaviors to self-monitoring: a functional analysis. Addict Behav 1980; 5: 209-17.
41. Sieck WA, McFall RM. Some determinants of self-monitoring effects. J Consult Clin Psychol 1976; 44: 958-65.
42. Kruger J, Blanck HM, Gillespie C. Dietary and physical activity behaviors among adults successful at weight loss maintenance. Int J Behav Nutr Phys Act 2006; 3: 17.
43. Labib M. The investigation and management of obesity. J Clin Pathol 2003; 56 (1): 17-25.
44. Sieck WA, McFall RM. Some determinants of self-monitoring effects. J Consult Clin Psychol 1976 December; 44 (6): 958-65.
45. Halme L, Vesalainen R, Kaaja M, Kantola I. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care. Am J Hypertens 2005; 18: 1415-20.
46. Febbraro GAR, Clum GA. Meta-analytic investigation of the effectiveness of selfregulatory components in the treatment of adult problems behaviors. Clin Psychol Rev 1998; 18: 143-61.
47. Steven AH, Dennis LW, Gail AH. Effects of expectancy of outcome on the reactivity of self-monitoring. J Psychopathol Behav Assess 1979; 1: 281-8.
48. Mace FC, Shapiro ES, West BJ, Campbell C, Altman J. The role of reinforcement in reactive self-monitoring. Appl Res Ment Retard 1986; 7: 315-27.
49. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006; 7: 159-64.
50. Frederiksen L-W, Epstein L-H, Kosevsky B-P. Reliability and controlling effects of three procedures for self-monitoring smoking. Psychol Rec 1963; 25: 255-63.
51. Labib M. The investigation and management of obesity. J Clin Pathol 2003; 56: 17-25.
52. Scheier MF, Carver CS. Goals and confidence as self-regulatory elements underlying health and illness behaviour. In: Cameron LD, Leventhal H (eds), The Self-Regulation of Health and Illness Behaviour. London: Taylor Francis, 2003.
53. Bandura A. Health promotion from the perspective of social cognitive theory. In: Norman P, Abraham C, Conner M (eds), Understanding and Changing Behaviour. Amsterdam: Harwood Academic, 2000.
54. Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H (eds), The Self-Regulation of Health and Illness Behaviour. London: Routledge, 2003.
55. Kaptein AA, Scharloo M, Helder DI, Kleijn WC, van Korlaar IM, Woertman M. Representations of chronic illness. In: Cameron LD, Leventhal H (eds), The Self-Regulation of Health and Illness Behaviour. London: Routledge, 2003.
56. Michie S,Weinman J, Miller J, Colins V, Halliday J, Marteau TM. Predictive genetic testing: high risk expectations in the face of low risk information. J Behav Med 2002; 25: 33-50.
57. Michie S, Smith J, Senior B, Marteau TM. Understanding why negative test results sometimes fail to reassure. Am J Med Genet 2003; 119A: 340-7.
58. Skinner BF. Science of Human Behavior. New York: Free Press, 1953.
59. Nemeroff CJ, Karoly P. Operant methods. In: Kanfer FH, Goldstein AP (eds), Helping People Change: A Textbook of Methods. London: Allyn and Bacon, 1991.
60. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998; 280: 550-8.
61. Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96: 525-31.
62. Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'metaepidemiological' research. Stat Med 2002; 21: 1513-24.
63. Kahan BD, Keown P, Levy GA, Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 2002; 24: 330-50.
64. Preskorn SH, Jerkovich GS. Central nervous system toxicity of tricyclic antidepressants: phenomenology, course risk factors, and the role of therapeutic drug monitoring. J Clin Psychopharmacol 1991; 10: 88-95.
65. Raebel MA, Lyons EE, Chester EA, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med 2005; 165: 2395-401.
66. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: 1-72.
67. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2006; 19 (2): CD005182.
68. Forrest S, McCaffery KJ,Waller J, Desai M, Swarewski A,Wardle J. Attitudes to selfsampling among Indian, Pakistani, African Caribbean and White British women in Manchester. J Med Screen 2004; 11: 85-8.
69. Sunderji R, Gin K, Shalansky K, et al. A randomized control trial of patient selfmanaged versus physical-managed oral anticoagulation. Can J Cardiol 2004; 20: 1117-23.
70. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998; 3 (Suppl 1): 19-24.
71. Gallichan MJ. Self-monitoring by patients receiving oral hypoglycaemic agents: a survey and a comparative trial. Pract Diabetes 1994; 11: 28-30.
72. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
73. Davidson MB. Counterpoint. Self-monitoring of blood glucose in type 2 diabetes patients not receiving insulin: a waste of money. Diabetes Care 2005; 28: 1531-3.
74. Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost 2004; 2: 584-91.
75. Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom selfmonitoring of asthma initiated from community pharmacies. J Clin Pharm Ther 2001; 26: 287-96.
76. Boggs PB, Wheeler D, Washburne WF, Hayati F. Peak expiratory flow rate control chart in asthma care: chart construction and use in asthma care. Ann Allergy Asthma Immunol 1998; 81: 552-62.
77. March L, Irwig L, Schwartz J, Simpson J, Chock C, Brooks P. N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994; 309: 1041-5.
78. Sheather-Reid RB, Cohen ML. Psychophysical evidence for a neuropathic component of chronic neck pain. Pain 1998; 75: 341-7.
79. Haines DR, Gaines SP. N of 1 randomized controlled trials of oral ketamine in patients with chronic pain. Pain 1999; 83: 283-7.
80. Wegman AC, van derWindt DA, de Haan M, Deville WL, Fo CT, de Vries TP. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Ann Rheum Dis 2003; 62: 1156-61.
81. Woodfield R, Goodyear-Smith F, Arroll B. N of 1 trials of quinine efficacy in skeletal muscle cramps of the leg. Br J Gen Pract 2005; 55: 181-5.
82. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Clavarino A, Yelland MJ. Preliminary experiences with a single-patient trials service in general practice. Med J Aust 2000; 173: 100-3.